From left to right: (Ying Tang, Vice President, Head of Business Operation, Healthcare, Merck China; Rogier Janssens, Managing Director and General Manager, Biopharma, Merck China; Chris Round, Executive Vice President, Head of International Operation & Global Core Franchise, Healthcare, Merck; Meng Zhang, Vice President, Tencent Medical; Jordan Liu, Strategy and Business Development Director, Tencent Medical). Photo credit: Merck
January 24, 2019
Yesterday, Merck, a German multinational pharmaceutical, chemical and life sciences company, and Tencent, a Chinese multinational investment holding conglomerate, signed a strategic collaboration agreement. The collaboration will primarily focus on increasing public disease awareness and providing more accessible healthcare services via digital platforms in China.
“In this collaboration with...
January 23, 2019
Digitimes, a supply side electronics publication with a mixed track record on Apple rumors, is reporting that Apple plans to launch next-generation AirPods in 2019 which will include health monitoring features. Giving credence to the rumor is an older report from November that Apple had updated certain trademarks pertaining to the AirPods to include health sensors.
The rumor doesn't include...
Credit: Ping An Good Doctor
January 22, 2019
Ping An Good Doctor, a one-stop healthcare ecosystem platform from China, recently announced that their “Voiceprint Login System” (“Voiceprint Lock”), jointly developed with Unisound, an intelligent voice and language technology company in China, has achieved a login success rate close to 99%. The breakthrough came after several model optimisations and upgrades.
In December 2017, Ping An Good...
January 17, 2019
Earlier today, Johnson & Johnson announced plans for a multi-year research program it will be launching with Apple to explore the role Apple Watches could play in senior health monitoring.
Set to kickoff later this year, the pragmatic randomized controlled trial study will be conducted in the US and enroll adults aged 65 years or older, according to a statement. Specifically, the primary...
The Misfit Vapor 2, a smartwatch from Fossil Group.
January 17, 2019
Google has agreed to pay $40 million to acquire a still-under-development smartwatch technology from Fossil Group. While the companies have not disclosed much about the technology in question, there is reason to believe it is health or wellness-related.
Greg McKelvey, EVP and chief strategy and digital officer of the Fossil Group, told Wareable that the technology is something that grew out of...
January 16, 2019
The National Institutes of Health made it clear from the start that Fitbit’s wearables would play a key role in the agency’s ambitious All of Us Research Program.
Now, eight months and more than 100,000 enrollees down the road, the agency and the device maker have announced that anyone who owns a Fitbit and has already enrolled in the program may consent to release the activity, heart rate, sleep...
January 15, 2019
In light of its recent CE Mark, Kraków, Poland-based respiratory health company FindAir will begin sales of its digital inhaler add-on to European consumers tomorrow, the company announced in a press release.
The FindAir One device wirelessly connects to an accompanying mobile and web app for patients and doctors alike.
For the former, the app passively collects data with each use to monitor the...
January 11, 2019
CES 2019 is in its waning days, and with its end comes a time for reflection. This year’s consumer tech expo boasted no shortage of health and wellness products on display, ranging from novel ECG-equipped wearables to novel approaches to skin care.
Meanwhile, the Digital Health Summit — CES’ sub-event focused exclusively on health technology — celebrated its tenth year at the show with two full...
January 11, 2019
The Embrace2, a seizure monitoring wearable from Boston and Milan-based Embrace, has received an updated FDA clearance that allows it to be used by children ages six and up — the first such device to receive clearance for pediatric use.
"The fact that this is the first clearance of its kind in epilepsy highlights how difficult it is to get robust results with pediatric patients in a clinical...
Photo: Dr. James Creeden, Global Medical Director of Foundation Medicine. Credit: Foundation Medicine.
January 10, 2019
Launched in 2010 with a $25 million Series A financing led by Third Rock Ventures, Foundation Medicine released its first commercial assay called FoundationOne in 2012. The company develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumours, hematologic malignancies, and sarcomas. In December 2017, the company’s assay FoundationOne...